Needle exchange access in federal prisons
Part of Digestive system, Infections clinical trials.
This study looks at whether making needle and syringe programs easier to use helps more people in prison get clean needles. It's about reducing infection risks for everyone at the participating prisons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently living at one of the prisons where the study is happening.
- No other requirements—this program is available to everyone at the site.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study provides safer, low-dead-space syringes to people who inject drugs to help reduce the spread of infections like HIV and hepatitis C. It is designed for people in low- and middle-income countries who use needle exchange programs.
This study helps people recently diagnosed with HIV in prison inform their partners. If you have been sexually active or shared needles in the year before your current stay, this research may be for you.
This study looks at ways to improve HIV prevention and treatment for people on probation who have injected opioids. Researchers want to learn from your experiences to help create better services.
This study helps men recently released from jail who inject drugs to start and stay on PrEP, a daily medicine that prevents HIV. The goal is to support them in taking PrEP regularly and staying connected to care.
This study helps people with HIV or high risk of HIV who have had substance use problems and are in jail or recently released. It tests a program called SUCCESS-E to support health and reduce drug use.
This study tests a better way to start long-acting HIV prevention (PrEP) and buprenorphine for opioid use disorder while people are in jail, to see if it helps them stay healthy after release. If you are soon leaving jail and have opioid use disorder, you may be able to join.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.